Anxiety and depression in patients with end-stage renal disease: Impact and management challenges – A narrative review

International Journal of Nephrology and Renovascular Disease

Volumn 11, Issue , 2018, Pages 93-102

  Goh, Zhong Sheng ^a   Griva, Konstadina ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Chronic kidney disease; Difficulties; Psychological; Symptoms

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ANXIETY; ANXIETY ASSESSMENT; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DEPRESSION ASSESSMENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EDUCATIONAL STATUS; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MENTAL DISEASE; MORTALITY RISK; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PSYCHOSOMATIC DISORDER; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SOCIAL STATUS; TREATMENT OUTCOME;

EID: 85049806614     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S126615     Document Type: Review

References (88)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047.
2. Tabish SA. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci (Qassim). 2007;1(2):V–VIII.
3. Cukor D, Cohen SD, Peterson RA, Kimmel PL. Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness. J Am Soc Nephrol. 2007;18(12):3042–3055.
4. Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84(1):179–191.
5. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.
6. Veater NL, East L. Exploring depression amongst kidney transplant recipients: a literature review. J Ren Care. 2016;42(3):172–184.
7. Davison GC, Neale JM. Abnormal Psychology. 8th ed. New York: John Wiley; 2004.
8. Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006;69(9):1662–1668.
9. Baumeister H, Härter M. Mental disorders in patients with obesity in comparison with healthy probands. Int J Obes (Lond). 2007;31(7): 1155–1164.
10. Ormel J, von Korff M, Burger H, et al. Mental disorders among persons with heart disease – results from World Mental Health surveys. Gen Hosp Psychiatry. 2007;29(4):325–334.
11. Kimmel PL, Thamer M, Richard CM, Ray NF. Psychiatric illness in patients with end-stage renal disease. Am J Med. 1998;105(3): 214–221.
12. Hedayati SS, Jiang W, O’Connor CM, et al. The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure. Am J Kidney Dis. 2004;44(2):207–215.
13. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis. 2009;54(4):741–752.
14. Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(3):484–490.
15. Cukor D, Coplan J, Brown C, et al. Anxiety disorders in adults treated by hemodialysis: a single-center study. Am J Kidney Dis. 2008;52(1):128–136.
16. Preljevic VT, Østhus TB, Sandvik L, et al. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. Gen Hosp Psychiatry. 2011;33(5):454–461.
17. Ng HJ, Tan WJ, Mooppil N, Newman S, Griva K. Prevalence and patterns of depression and anxiety in hemodialysis patients: a 12-month prospective study on incident and prevalent populations. Br J Health Psychol. 2015;20(2):374–395.
18. Chilcot J, Norton S, Wellsted D, Davenport A, Firth J, Farrington K. Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptions. Ann Behav Med. 2013;45(1):78–88.
19. Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ. Prevalence of major depressive episode in CKD. Am J Kidney Dis. 2009;54(3):424–432.
20. Fischer MJ, Kimmel PL, Greene T, et al; AASK study group. Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease. Kidney Int. 2010;77(11): 1010–1019.
21. Kop WJ, Seliger SL, Fink JC, et al. Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol. 2011;6(4):834–844.
22. Yu ZL, Yeoh LY, Seow YY, Luo XC, Griva K. Evaluation of adherence and depression among patients on peritoneal dialysis. Singapore Med J. 2012;53(7):474–480.
23. Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis. 2003;42(2):350–354.
24. Griva K, Davenport A, Harrison M, Newman S. An evaluation of illness, treatment perceptions, and depression in hospital-vs. home-based dialysis modalities. J Psychosom Res. 2010;69(4):363–370.
25. Griva K, Kang AW, Yu ZL, et al. Quality of life and emotional distress between patients on peritoneal dialysis versus community-based hemodialysis. Qual Life Res. 2014;23(1):57–66.
26. Bro S, Bjorner JB, Tofte-Jensen P, et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int. 1999;19(6):526–533.
27. Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1(6):1191–1196.
28. Theofilou P. Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. J Clin Med Res. 2011;3(3):132–138.
29. Noshad H, Sadreddini S, Nezami N, Salekzamani Y, Ardalan MR. Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients. Singapore Med J. 2009;50(2):185–192.
30. Griva K, Li ZH, Lai AY, Choong MC, Foo MW. Perspectives of patients, families, and health care professionals on decision-making about dialysis modality – the good, the bad, and the misunderstandings! Perit Dial Int. 2013;33(3):280–289.
31. Lin YH, Yang Y, Chen SY, Chang CC, Chiu PF, Huang CY. The depression status of patients with end-stage renal disease in different renal replacement therapies. Int J Urol Nurs. 2011;5(1):14–20.
32. Mittal SK, Ahern L, Flaster E, Mittal VS, Maesaka JK, Fishbane S. Self-assessed quality of life in peritoneal dialysis patients. Am J Nephrol. 2001;21(3):215–220.
33. Griva K, Goh CS, Kang WC, et al. Quality of life and emotional distress in patients and burden in caregivers: a comparison between assisted peritoneal dialysis and self-care peritoneal dialysis. Qual Life Res. 2016;25(2):373–384.
34. Moore R, Teitelbaum I. Preventing burnout in peritoneal dialysis patients. Adv Perit Dial. 2009;25:92–95.
35. García-García G, Harden P, Chapman J; World Kidney Day Steering Committee 2012. The global role of kidney transplantation. Nefrologia. 2012;32(1):1–6. Spanish.
36. Terán-Escandón D, Ruiz-Ornelas J, Estrada-Castillo JG, Barajas-Juárez L, Díaz-Martínez A. Anxiety and depression among renal transplantation candidates: impact of donor availability. Actas Esp Psiquiatr. 2001;29(2):91–94 [Article in Spanish].
37. Tong A, Hanson CS, Chapman JR, et al. “Suspended in a paradox” – patient attitudes to wait-listing for kidney transplantation: systematic review and thematic synthesis of qualitative studies. Transpl Int. 2015;28(7):771–787.
38. Hedayati SS, Bosworth HB, Briley LP, et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008;74(7):930–936.
39. McDade-Montez EA, Christensen AJ, Cvengros JA, Lawton WJ. The role of depression symptoms in dialysis withdrawal. Heal Psychol. 2006;25(2):198–204.
40. Abbas Tavallaii S, Ebrahimnia M, Shamspour N, Assari S. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur J Intern Med. 2009;20(4):411–414.
41. Mapes DL, Bragg-Gresham JL, Bommer JJ, et al. Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(5 Suppl 2):54–60.
42. Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV. Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(4): 623–635.
43. Palmer SC, Vecchio M, Craig JC, et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis. 2013;62(3):493–505.
44. Boulware LE, Liu Y, Fink NE, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol. 2006;1(3):496–504.
45. Tsai YC, Chiu YW, Hung CC, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.
46. Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA. 2010;303(19):1946–1953.
47. Novak M, Molnar MZ, Szeifert L, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med. 2010;72(6):527–534.
48. Bayat S, Frimat L, Thilly N, Loos C, Briançon S, Kessler M. Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care. Nephrol Dial Transplant. 2006;21(10):2900–2907.
49. Szeifert L, Bragg-Gresham JL, Thumma J, et al. Psychosocial variables are associated with being wait-listed, but not with receiving a kidney transplant in the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2012;27(5):2107–2113.
50. Ko GJ, Kim MG, Yu YM, Jo SK, Cho WY, Kim HK. Association between depression symptoms with inflammation and cardiovascular risk factors in patients undergoing peritoneal dialysis. Nephron Clin Pract. 2010;116(1):c29–c35.
51. Juergensen PH, Juergensen DM, Wuerth DB, et al. Psychosocial factors and incidence of peritonitis. Adv Perit Dial. 1996;12:196–198.
52. Cukor D, Ver Halen N, Fruchter Y. Anxiety and quality of life in ESRD. Semin Dial. 2013;26(3):265–268.
53. Loosman WL, Rottier MA, Honig A, Siegert CE. Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study. BMC Nephrol. 2015;16(1):155.
54. Honda H, Qureshi AR, Heimbürger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47(1):139–148.
55. Taraz M, Taraz S, Dashti-Khavidaki S. Association between depression and inflammatory/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: a review of literature. Hemodial Int. 2015;19(1):11–22.
56. Simic Ogrizovic S, Jovanovic D, Dopsaj V, et al. Could depression be a new branch of MIA syndrome? Clin Nephrol. 2009;71(2):164–172.
57. Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998;54(1):245–254.
58. Kaveh K, Kimmel PL. Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis. 2001;37(2):244–266.
59. Leggat JE Jr. Adherence with dialysis: a focus on mortality risk. Semin Dial. 2005;18(2):137–141.
60. Pompili M, Venturini P, Montebovi F, et al. Suicide risk in dialysis: review of current literature. Int J Psychiatry Med. 2013;46(1):85–108.
61. Hou Y, Li X, Yang L, et al. Factors associated with depression and anxiety in patients with end-stage renal disease receiving maintenance hemodialysis. Int Urol Nephrol. 2014;46(8):1645–1649.
62. Lopes AA, Bragg J, Young E, et al; Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62(1):199–207.
63. Yoong RK, Mooppil N, Khoo EY, et al. Prevalence and determinants of anxiety and depression in end stage renal disease (ESRD). a comparison between ESRD patients with and without coexisting diabetes mellitus. J Psychosom Res. 2017;94:68–72.
64. Sesso R, Rodrigues-Neto JF, Ferraz MB. Impact of socioeconomic status on the quality of life of ESRD patients. Am J Kidney Dis. 2003;41(1):186–195.
65. Vázquez I, Valderrábano F, Jofré R, et al; Spanish Cooperative Renal Patients Quality of Life Study Group. Psychosocial factors and quality of life in young hemodialysis patients with low comorbidity. J Nephrol. 2003;16(6):886–894.
66. Theofilou P. Depression and anxiety in patients with chronic renal failure: the effect of sociodemographic characteristics. Int J Nephrol. 2011;2011:514070.
67. Spencer BW, Chilcot J, Farrington K. Still sad after successful renal transplantation: are we failing to recognise depression? An audit of depression screening in renal graft recipients. Nephron Clin Pract. 2011;117(2):c106–c112.
68. Sensky T. Psychiatric morbidity in renal transplantation. Psychother Psychosom. 1989;52(1–3):41–46.
69. Ouellette A, Achille MA, Vachon M. Psychological impact of kidney graft failure and implications for the psychological evaluation of re-transplant candidates. Dial Transplant. 2006;35(6):354–361.
70. Gill P, Lowes L. Renal transplant failure and disenfranchised grief: participants’ experiences in the first year post-graft failure – a qualitative longitudinal study. Int J Nurs Stud. 2014;51(9): 1271–1280.
71. Chilcot J. The importance of illness perception in end-stage renal disease: associations with psychosocial and clinical outcomes. Semin Dial. 2012;25(1):59–64.
72. Leventhal H, Meyer D, Nerenz DR. The common sense representation of illness danger. In: Rachman S, editor. Contributions to Medical Psychology. New York: Pergamon Press; 1980:17–30.
73. Clarke AL, Yates T, Smith AC, Chilcot J. Patient’s perceptions of chronic kidney disease and their association with psychosocial and clinical outcomes: a narrative review. Clin Kidney J. 2016;9(3): 494–502.
74. Christensen AJ, Turner CW, Smith TW, Holman JM Jr, Gregory MC. Health locus of control and depression in end-stage renal disease. J Consult Clin Psychol. 1991;59(3):419–424.
75. Griva K, Jayasena D, Davenport A, Harrison M, Newman SP. Illness and treatment cognitions and health related quality of life in end stage renal disease. Br J Health Psychol. 2009;14(Pt 1): 17–34.
76. Knowles S, Swan L, Salzberg M, Castle D, Langham R. Exploring the relationships between health status, illness perceptions, coping strategies and psychological morbidity in a chronic kidney disease cohort. Am J Med Sci. 2014;348(4):271–276.
77. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–S153.
78. Tong A, Sainsbury P, Carter SM, et al. Patients’ priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23(10):3206–3214.
79. Schipper K, Abma TA. Coping, family and mastery: top priorities for social science research by patients with chronic kidney disease. Nephrol Dial Transplant. 2011;26(10):3189–3195.
80. Lopes AA, Albert JM, Young EW, et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 2004;66(5):2047–2053.
81. Raymond CB, Wazny LD, Honcharik PL. Pharmacotherapeutic options for the treatment of depression in patients with chronic kidney disease. Nephrol Nurs J. 2008;35(3):257–263.
82. Palmer SC, Natale P, Ruospo M, et al. Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. Cochrane Database Syst Rev. 2016;2016(5):CD004541.
83. Pascoe MC, Thompson DR, Castle DJ, McEvedy SM, Ski CF. Psychosocial interventions for depressive and anxiety symptoms in individuals with chronic kidney disease: systematic review and meta-analysis. Front Psychol. 2017;8:992.
84. Lerma A, Perez-Grovas H, Bermudez L, Peralta-Pedrero ML, Robles-García R, Lerma C. Brief cognitive behavioural intervention for depression and anxiety symptoms improves quality of life in chronic haemodialysis patients. Psychol Psychother. 2017;90(1):105–123.
85. Beck AT, Dozois DJ. Cognitive therapy: current status and future directions. Annu Rev Med. 2011;62:397–409.
86. Hudson JL, Moss-Morris R, Game D, Carroll A, Chilcot J. Improving distress in dialysis (iDiD): a tailored CBT self-management treatment for patients undergoing dialysis. J Ren Care. 2016;42(4):223–238.
87. NICE. Depression in adults with a chronic physical health problem. The NICE guideline on treatment and management. 2010. Available from: http://guidance.nice.org.uk/CG91/QuickRefGuide/pdf/English. Accessed October 9, 2017.
88. Finkelstein FO, Wuerth D, Finkelstein SH. An approach to addressing depression in patients with chronic kidney disease. Blood Purif. 2010;29(2):121–124.